Shattuck Labs, Inc.
CSF1R-BASED CHIMERIC PROTEINS
Last updated:
Abstract:
The present invention relates, in part, to, chimeric proteins which include the extracellular domain of colony stimulating factor 1 receptor (CSF1R) and their use in the treatment of diseases, such as immunotherapies for cancer and/or an inflammatory disease.
Status:
Application
Type:
Utility
Filling date:
27 Feb 2018
Issue date:
19 Dec 2019